Gordian Founder: Verifiability Means AI Cracks Cancer Before Alzheimer's
MaxUnfried · x · 2026-08-18
Martin Jensen of Gordian Biotechnology offers a cross-domain analogy: AI drug discovery will crack cancer before Alzheimer's for the same reason AI handles math and code but not financial markets — verifiability.
- Biotech is fundamentally about building confidence in whether an approach works, and it thrives when there's a super clear outcome signal: weight-loss peptides show results in two weeks, a scan can show a tumor is gone.
- Preventing heart attacks or slowing Alzheimer's yields much murkier, longer-horizon signals, making them far harder targets.
More from AGI Musings
- Which path to AGI: transformers scale directly, invent a successor, or just help build one? — flowersslop · 2026-08-18
- Vinod Khosla: Humans degrade the performance of good AI — Scobleizer · 2026-08-18
- Neolab Onboarding: OpenAI and Anthropic Both Racing to the Bottom on Safety — nabla_theta · 2026-08-18
- Regulate unlawful conduct, not the AI tool itself, argues legal commentator — TinfoilTricorn · 2026-08-18
- Lawyers' AI-Assisted Filings Face Court Rules Raising First Amendment Concerns — TinfoilTricorn · 2026-08-18
- Expensive cognitive labor has bigger incentive to automate — VraserX · 2026-08-18